CSI Market
Sign In | Register

Apimeds Pharmaceuticals US (APUS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access APUS Annual Balance Sheets →
A period-by-period view of the balance sheet from Apimeds Pharmaceuticals US to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.28
Cash, Cash Equivalents Other8.00
Marketable Securities0.00
Cash & Short-term Investments8.00
Total loans net2.24
Total Current Assets10.68
Equipment/Property/Plant Net0.07
Long-term investments3.00
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.87
Other Assets, Noncurrent113.01
Total Assets127.62
Liabilities
Accounts Payable3.22
Accrued Liabilities, Current0.78
Financial Instruments1.35
Short-term Debt0.00
Other Liabilities, Current1.81
Total Current Liabilities21.07
Long-term debt5.00
Long-term Debt Convertible0.45
Total Long-term Debt5.45
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent8.56
Total Liabilities21.18
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock168.44
Retained Earnings / Accumulated Deficit-65.63
Defined Benefit Plan and Other0.00
Common Stockholder's Equity102.81
Preferred Stockholder's Equity0.00
Non-controlling interests & other3.64
Total Stockholder's Equity106.45
Liabilities & Stockholder's Equity127.62
4 historic quarters locked

Sign in to unlock the full Apimeds Pharmaceuticals US balance sheet history.

Sign In Create Free Account

About Apimeds Pharmaceuticals Us Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-090120

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.